PARKINSON DISEASE
Clinical trials for PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Parkinson's pill trial halted early after testing in small group
Disease control TerminatedThis early-stage study tested whether an oral medication called VENT-02 is safe for people with mild to moderate Parkinson's disease. About 30 participants took either the drug or a placebo pill twice daily for 28 days while researchers monitored for side effects and measured inf…
Matched conditions: PARKINSON DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test if sweat can slow Parkinson's
Disease control TerminatedThis study tested whether a program of intensive physical activity could help control Parkinson's disease progression. Researchers compared 30 patients with Parkinson's who followed an exercise program to those who remained mostly inactive. They measured changes in movement sympt…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Swallow sensor trial halted after failing to match gold standard
Diagnosis TerminatedThis study tested a new device called the Dysphagia Detection System (DDS), which is a small sensor worn on the neck. Researchers wanted to see if it could accurately detect unsafe or inefficient swallowing in people with conditions like stroke, Parkinson's, and dementia, compare…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Mar 16, 2026 15:25 UTC
-
Could a Parkinson's pill rekindle lost interests?
Symptom relief TerminatedThis study aimed to see if an already-approved Parkinson's disease medication called istradefylline could help improve motivation and reduce apathy—a common symptom where people lose interest in activities. It planned to test this over 12 weeks in a small group of people with Par…
Matched conditions: PARKINSON DISEASE
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Quick-Puff treatment tested for Parkinson's symptom flares
Symptom relief TerminatedThis study tested an inhaled form of the drug apomorphine (called AZ-009) to see if it could quickly relieve the return of Parkinson's symptoms, known as 'OFF' episodes, when regular oral medications wear off. It involved about 50 adults with established Parkinson's who experienc…
Matched conditions: PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC